These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8223852

  • 21. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N, Nishimura H, Wajjwalku W, Ando Y, Nagafuchi S, Watanabe T, Yoshikai Y.
    J Immunol; 1997 Sep 01; 159(5):2189-95. PubMed ID: 9278306
    [Abstract] [Full Text] [Related]

  • 22. Delay in expression of a mammary tumor provirus is responsible for defective clonal deletion during postnatal period.
    Niimi N, Wajjwalku W, Ando Y, Tomida S, Takeuchi M, Ueda M, Kaneda T, Yoshikai Y.
    Eur J Immunol; 1994 Feb 01; 24(2):488-91. PubMed ID: 8299700
    [Abstract] [Full Text] [Related]

  • 23. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM, Wallace VA, Timms E, Mak TW.
    Eur J Immunol; 1994 May 01; 24(5):1102-8. PubMed ID: 8181521
    [Abstract] [Full Text] [Related]

  • 24. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer.
    Wang Y, Jiang JD, Xu D, Li Y, Qu C, Holland JF, Pogo BG.
    Cancer Res; 2004 Jun 15; 64(12):4105-11. PubMed ID: 15205319
    [Abstract] [Full Text] [Related]

  • 25. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
    Foo-Phillips M, Kozak CA, Principato MA, Abe R.
    J Immunol; 1992 Dec 01; 149(11):3440-7. PubMed ID: 1331236
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Reevaluation of the effect of mouse mammary tumor virus infection on the BALB/c mouse hyperplastic outgrowth.
    Ashley RL, Cardiff RD, Fanning TG.
    J Natl Cancer Inst; 1980 Nov 01; 65(5):977-86. PubMed ID: 6253710
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Intervention of T-cells in transportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vivo.
    Tsubura A, Inaba M, Imai S, Murakami A, Oyaizu N, Yasumizu R, Ohnishi Y, Tanaka H, Morii S, Ikehara S.
    Cancer Res; 1988 Nov 15; 48(22):6555-9. PubMed ID: 2846153
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
    Xu L, Wrona TJ, Dudley JP.
    Virology; 1997 Sep 15; 236(1):54-65. PubMed ID: 9299617
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Development and characterization of mouse hyperplastic mammary outgrowth lines from BALB/cfC3H hyperplastic alveolar nodules.
    Ashley RL, Cardiff RD, Mitchell DJ, Faulkin LJ, Lund JK.
    Cancer Res; 1980 Nov 15; 40(11):4232-42. PubMed ID: 6258774
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.